MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bph.15963

Медицинская библиотека · British journal of pharmacology · 2022

Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation.

Clemente-Moragón Agustín, Oliver Eduardo, Calle Daniel, Cussó Lorena, Gómez Mónica, Pradillo Jesús M, Castejón Raquel, Rallón Norma, Benito José M, Fernández-Ferro José C, Carneado-Ruíz Joaquín, Moro María A, Sánchez-González Javier, Fuster Valentín, Cortés-Canteli Marta, Desco Manuel, Ibáñez Borja

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND PURPOSE: Reperfusion therapy is the standard of care for ischaemic stroke; however, there is a need to identify new therapeutic targets able to ameliorate cerebral damage. Neutrophil β1 adrenoceptors (β1AR) have been linked to neutrophil migration during exacerbated inflammation. Given the central role of neutrophils in cerebral damage during stroke, we hypothesize that β1AR blockade will improve stroke outcomes.

EXPERIMENTAL APPROACH: Rats were subjected to middle cerebral artery occlusion-reperfusion to evaluate the effect on stroke of the selective β1AR blocker metoprolol (12.5 mg·kg-1 ) when injected i.v. 10 min before reperfusion.

KEY

RESULTS

Magnetic resonance imaging and histopathology analysis showed that pre-reperfusion i.v. metoprolol reduced infarct size. This effect was accompanied by reduced cytotoxic oedema at 24 h and vasogenic oedema at 7 days. Metoprolol-treated rats showed reduced brain neutrophil infiltration and those which infiltrated displayed a high proportion of anti-inflammatory phenotype (N2, YM1+ ). Additional inflammatory models demonstrated that metoprolol specifically blocked neutrophil migration via β1AR and excluded a significant effect on the glia compartment. Consistently, metoprolol did not protect the brain in neutrophil-depleted rats upon stroke. In patients suffering an ischaemic stroke, β1AR blockade by metoprolol reduced circulating neutrophil-platelet co-aggregates.

CONCLUSIONS AND IMPLICATIONS: Our findings describe that β1AR blockade ameliorates cerebral damage by targeting neutrophils, identifying a novel therapeutic target to improve outcomes in patients with stroke. This therapeutic strategy is in the earliest stages of the translational pathway and should be further explored.

Для цитирования: Clemente-Moragón Agustín, Oliver Eduardo, Calle Daniel, Cussó Lorena, Gómez Mónica, Pradillo Jesús M, Castejón Raquel, Rallón Norma, Benito José M, Fernández-Ferro José C, Carneado-Ruíz Joaquín, Moro María A, Sánchez-González Javier, Fuster Valentín, Cortés-Canteli Marta, Desco Manuel, Ibáñez Borja. Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation.. British journal of pharmacology. 2022. DOI: 10.1111/bph.15963.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.